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A B S T R A C T
Background: The “Avolition-apathy” domain of the negative symptoms was found to include diﬀerent symptoms
by factor analytic studies on ratings derived by diﬀerent scales. In particular, the relationship of anhedonia with
this domain is controversial. Recently introduced negative symptom rating scales provide a better assessment of
anhedonia, allowing the distinction of anticipatory and consummatory aspects, which might be related to dif-
ferent psychopathological dimensions. The study of associations with external validators, such as electro-
physiological, brain imaging or cognitive indices, might shed further light on the status of anhedonia within the
Avolition-apathy domain.
Objectives: We used brain electrical microstates (MSs), which represent subsecond periods of quasi-stable scalp
electrical ﬁeld, associated with resting-state neural networks (and thus with global patterns of functional con-
nectivity), to test whether the component symptoms of Avolition-apathy share the same correlates.
Method: We analyzed multichannel resting EEGs in 142 individuals with schizophrenia (SCZ) and in 64 healthy
controls (HC), recruited within the add-on EEG study of the Italian Network for Research on Psychoses. Relative
time contribution, duration and occurrence of four MS classes (MS-A/-B/-C/−D) were calculated. Group dif-
ferences on MS parameters (contribution and duration) and their associations with negative symptom domains
(assessed using the Brief Negative Symptoms Scale) were investigated.
Results: SCZ, in comparison to HC, showed increased contribution and duration of MS-C. The contribution of MS-
A positively correlated with Avolition-apathy, but not with Expressive deﬁcit. Within the Avolition-apathy
domain, anticipatory anhedonia, avolition and asociality, but not consummatory anhedonia, showed the same
correlations with MS-A contribution.
Conclusion: Our ﬁndings support the existence of distinct electrophysiological correlates of Avolition-apathy
with respect to Expressive deﬁcit, and lend support to the hypothesis that only the anticipatory component of
anhedonia shares the same pathophysiological underpinnings of the Avolition-apathy domain.
1. Introduction
Negative symptoms have long been considered a core feature of
schizophrenia (Kraepelin, 1919; Bleuler, 1959). They represent a
separate domain of the disease (Strauss et al., 1974; Kirkpatrick and
Fischer, 2006) and have been associated with poor functional outcome,
worse quality of life and poor response to pharmacological treatment
(Lysaker and Davis, 2004; Orsel et al., 2004; Wegener et al., 2005;
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Harvey et al., 2012; Galderisi et al., 2013a; Galderisi et al., 2013b;
Mucci et al., 2014; Mucci et al., 2017).
According to the literature, negative symptoms include blunted af-
fect (reduced intensity and range of emotional expression), alogia (re-
duced spontaneous speech and loss of conversational ﬂuency), avolition
(reduced interest and motivation for productive activities, or sense of
purpose), asociality (diminished interest in social drive or interest and
desire for aﬃliation) and anhedonia (reduced ability to experience or
anticipate pleasure) (Kirkpatrick and Fischer, 2006; Galderisi et al.,
2016; Galderisi et al., 2018).
Several factor analytic studies have reported that negative symp-
toms can be divided into two domains referred to as Avolition-apathy
(which includes avolition, anhedonia and asociality) and Expressive
deﬁcit (which includes alogia and blunted aﬀect) (Kimhy et al., 2006;
Galderisi et al., 2013a; Kirkpatrick, 2014a, 2014b). These two domains
have been shown to have diﬀerent behavioral and neurobiological
correlates and they may also be targeted by diﬀerent therapeutic op-
tions (Galderisi et al., 2013a; Kirkpatrick, 2014b; Galderisi et al., 2015;
Mucci et al., 2015; Kaiser et al., 2016; Kirschner et al., 2017; Marder
and Galderisi, 2017; Mucci et al., 2017).
Avolition-apathy has been associated with a dysfunction of brain
circuits involved in motivation (Gard et al., 2007; Heerey and Gold,
2007; Heerey et al., 2007; Waltz et al., 2007; Kring and Moran, 2008;
Barch and Dowd, 2010; Cohen and Minor, 2010; Dowd and Barch,
2010; Foussias and Remington, 2010; Pizzagalli, 2010; Simpson et al.,
2012; Mann et al., 2013; Strauss, 2013; Morris et al., 2015; Mucci et al.,
2015), in particular to those subtending the ability to anticipate plea-
sure and learn from rewards (Waltz et al., 2007; Gold et al., 2012;
Strauss, 2013) or to integrate reward value with performed actions
(Morris et al., 2015; Mucci et al., 2015; Waltz and Gold, 2016). These
functions are subtended by the circuit corresponding to the NIMH Re-
search Domain Criteria (https://www.nimh.nih.gov/research-
priorities/rdoc/index.shtml) “positive valence system” (Bromberg-
Martin et al., 2010; Miller et al., 2014; Bissonette and Roesch, 2016;
O'Doherty, 2016). This system involves dopamine neurons located in
the ventro-tegmental area (VTA) and in the ventro-medial substantia
nigra pars compacta (VMSNpc) with projections to orbito-frontal cortex
(OFC), ventro-medial prefrontal cortex (VMPFC), nucleus accumbens
(NA), dorsal striatum (DS), amygdala and insular cortex (Bromberg-
Martin et al., 2010; Galderisi et al., 2018).
Open issues in the ﬁeld include whether Avolition-apathy and all
component symptoms share the same neurobiological underpinnings, in
particular for what concerns the anticipatory (failure to anticipate re-
ward or pleasurable experiences) and consummatory aspects of anhe-
donia (in the moment experience of pleasure during pleasurable si-
tuations).
It is highly controversial whether consummatory anhedonia can be
found in non-depressed individuals with schizophrenia (Andreasen,
1982; Horan et al., 2006; Tremeau, 2006; Kring and Moran, 2008;
Tremeau et al., 2009; Cohen and Minor, 2010), as several studies
documented an intact ability to experience pleasure in the moment in
these subjects (Messinger et al., 2011; Kirkpatrick et al., 2017; Marder
and Galderisi, 2017). In contrast, an impairment in pleasure anticipa-
tion, due to a dysfunction of the motivation circuits, was consistently
reported in individuals with schizophrenia, both at ﬁrst-episode and
during the chronic phase of the disease (Gard et al., 2007; Heerey and
Gold, 2007; Heerey et al., 2007; Waltz et al., 2007; Kring and Moran,
2008; Barch and Dowd, 2010; Cohen and Minor, 2010; Foussias and
Remington, 2010; Pizzagalli, 2010; Dowd and Barch, 2012; Simpson
et al., 2012; Mann et al., 2013; Strauss, 2013; Morris et al., 2015). Thus,
only anticipatory anhedonia might share the same neurobiological
correlates of the Avolition-apathy domain (Barch et al., 2016). This
issue could not be tested adequately in the past. In fact, most of the old
assessment instruments either did not evaluate anhedonia or did not
distinguish between consummatory and anticipatory anhedonia
(Knutson et al., 2001; Horan et al., 2006; Berridge, 2007; Gard et al.,
2007; Blanchard et al., 2011). Indeed, both the Positive and Negative
Syndrome Scale (PANSS) (Kay et al., 1987) and the Scale for the As-
sessment of Negative Symptoms (SANS) (Andreasen, 1989) had several
limitations. The PANSS did not evaluate avolition and anhedonia, while
the SANS rated together anhedonia and asociality, and did not distin-
guish between the two aspects of anhedonia. These limitations have
been overcome by the introduction of second generation clinician-rated
scales, such as the Brief Negative Symptoms Scale (BNSS) (Kirkpatrick
et al., 2011), in which the anhedonia subscale has separate items for the
assessment of the intensity and frequency of pleasure during activities
(consummatory pleasure) in the last week and the intensity of expected
pleasure from future activities (anticipatory pleasure).
Some electrophysiological studies, investigating abnormalities of
reward anticipation and evaluation in individuals with schizophrenia,
found that anhedonia was associated with abnormal reward processing,
evaluated using the Stimulus Preceding Negativity (SPN) and the P300
event-related potential (ERP) (Wynn et al., 2010; Vignapiano et al.,
2016). In the study conducted by Wynn et al. (Wynn et al., 2010), the
SPN, a negative ERP component involved in the anticipation of feed-
back, correlated with trait anhedonia and with the total negative
symptoms score, assessed using the Scale for the Assessment of Nega-
tive Symptoms (SANS). Vignapiano et al. (2016) investigated cue P300
ERP components during the anticipation of reward and loss (using the
Monetary Incentive Delay task). They found that in healthy controls
and in individuals with schizophrenia, early P300 amplitude for large
reward and large loss was inversely related to social anhedonia, as-
sessed using the Chapman Social Anhedonia Scale (Chapman et al.,
1976). The same study did not ﬁnd any correlation of the P300 am-
plitude with the Avolition-apathy or Expressive deﬁcit domain.
The results of task-related ERP investigations could be confounded
by neurocognitive deﬁcits that are prominent in individuals with
schizophrenia (Heinrichs and Zakzanis, 1998; Green et al., 2000;
Galderisi et al., 2002; Bora et al., 2009; Galderisi et al., 2009; Bora
et al., 2010) and suﬀer from an a priori selection of the component of
interest.
For these reasons, ERP results might be integrated by com-
plementary analyses, using, for instance, indices of resting state activity
within distributed neural networks. One such method is the so-called
microstates analysis (Lehmann et al., 1987; Pascual-Marqui et al.,
1995). This kind of EEG analysis deﬁnes the global functional state of
the brain by its momentary scalp electric ﬁeld conﬁguration (Koenig
et al., 2002). Cluster analytical approaches showed that there is a small
set of prototypical microstate conﬁgurations, which constitutes a basic
repertoire of brain functional states. The sequence of microstates and
the rules governing these sequences may represent the subsecond
switching between various types of such integrative states (Khanna
et al., 2015). The microstates can be considered “atoms of thought”,
since they are associated with diﬀerent classes of mentation and reﬂect
the coordinated activity of distributed neural networks (Lehmann et al.,
1998). As a matter of fact, the diﬀerent microstate (MS) classes were
associated with distinct resting state neural networks (RSNs) in dif-
ferent studies, using diﬀerent methodologies (Britz et al., 2010; Yuan
et al., 2012; Pascual-Marqui et al., 2014; Custo et al., 2017), with only
few exceptions in which only one MS demonstrated a signiﬁcant asso-
ciation with two RSNs (Musso et al., 2010).
Two of the studies reporting a signiﬁcant association between MSs
and RSNs, used simultaneous EEG-fMRI recording (Britz et al., 2010;
Yuan et al., 2012). In the study conducted by Britz et al. (2010), the
authors extracted 4 MSs (MS-A/-B/-C/−D) and they reported that these
MSs were associated with BOLD signal within brain areas subtending
phonological, visual, salience and attention networks. Yuan et al.
(2012), using a temporal independent component analysis, extracted 13
MS and found that six of them were associated with one or two RSNs,
while the others to more than two networks.
The other studies investigated the relationships between MSs and
RSNs, applying source localization methods to multichannel data
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(Pascual-Marqui et al., 2014; Custo et al., 2017; Milz et al., 2017). The
four MS classes were found to be associated with sources in the anterior
and posterior cingulate cortices and bilateral parietal-occipital regions,
areas which belong to the default mode network (Pascual-Marqui et al.,
2014). A recent study (Custo et al., 2017), using a source localization
method closer to the approach used by Britz et al. (2010), extracted
seven maps and demonstrated that maps labelled as A, B, F and D
(corresponding to maps A-B-C-D in Britz et al., 2010) were linked to
similar RSNs described in Britz et al. (2010).
In addition, other studies attempted to alter the temporal char-
acteristics of the four MSs through behavioral manipulation (Milz et al.,
2016; Seitzman et al., 2017) and reported that temporal parameters of
MS-B were increased during visualization (Seitzman et al., 2017) or
verbalization (Milz et al., 2016), and those of MS-A were increased
during visualization (Milz et al., 2016).
Taking into account that MSs A and B have been linked to fronto-
temporal and occipital regions, areas belonging to the phonological and
visual networks and that MSs C and D have been linked to cingulate
cortex, right superior and middle frontal gyri, the right superior and
inferior parietal lobules, regions involved in the default mode, salience
and attention networks (Britz et al., 2010; Custo et al., 2017), it is
possible to extrapolate that MSs A and B reﬂect the extrinsic system of
distributed resting state connectivity (as demonstrated also by the task-
speciﬁc alteration of the temporal parameters of these two MSs), while
the other two classes are the expression of the intrinsic system (for
deﬁnition and characteristics of the two systems, see Doucet et al.,
2011; Orliac et al., 2017). Indeed, the extrinsic system is constituted by
two modules, which are located in the primary somatosensory areas
(M2a) and visual areas (M2b), while the intrinsic system includes three
modules that are involved in generation of spontaneous thoughts
(M1a), inner maintenance and manipulation of information (M1b),
cognitive control and switching activity (M1c).
Although the comparison of aforementioned studies is made diﬃ-
cult due to the methodological diﬀerences, taken together they sug-
gested a relationship between MSs and RSNs. Therefore, EEG microstate
analysis can be an advantageous, inexpensive, and non-invasive method
to assess global functional states of the brain and to correlate these
states with clinically relevant measures.
In individuals with schizophrenia, several studies have suggested
changes in MS topography and/or temporal parameters (Kinoshita
et al., 1998; Koenig et al., 1999; Strelets et al., 2003; Lehmann et al.,
2005; Kikuchi et al., 2007; Nishida et al., 2013; Tomescu et al., 2015).
All the aforementioned studies have suggested a reduced presence
of MSs B and D and increased presence of C and A (although the latter
alteration is far less consistent within studies) in individuals with
schizophrenia versus healthy controls.
A recent meta-analysis demonstrated that the reduced contribution
and duration of MS-D, the increased contribution and occurrence of MS-
C and the reduced duration of MS-B are consistent across studies
(Rieger et al., 2016); on the contrary, the meta-analysis did not de-
monstrate any consistent eﬀect for MS-A.
Some studies have reported that individual MS classes may be as-
sociated with speciﬁc clinical features of schizophrenia, such as hallu-
cinations, positive symptoms, duration of illness and negative symptom
total score (Stevens et al., 1997; Koenig et al., 1999; Kindler et al.,
2011; Andreou et al., 2014; Tomescu et al., 2015). In particular, MS-D
was found to be signiﬁcantly associated to paranoid-hallucinatory
symptomatology (Koenig et al., 1999) or to the experience of halluci-
nations (Kindler et al., 2011). An early study also has reported that, in
chronic individuals with schizophrenia, the overall average duration of
MSs was negatively correlated with the duration of disease and the
frequency of psychotic exacerbations and was positively correlated with
Brief Psychiatric Rating Scale (BPRS) total score and negative symp-
toms total score, assessed using the SANS (Stevens et al., 1997).
To our knowledge, no study has analyzed the correlates of the
Avolition-apathy domain using the MS analysis during a resting state
condition. Therefore, the current study had two primary aims: 1) to
identify diﬀerences between healthy controls and clinically stable in-
dividuals with schizophrenia with respect to MS parameters and 2) to
investigate the associations of these MS parameters with the Avolition-
apathy domain and its component symptoms, as assessed by a second-
generation rating scale, providing optimal assessment of consummatory
and anticipatory anhedonia.
2. Methods
2.1. Subjects
One hundred and forty-eight outpatients with schizophrenia (SCZ)
and seventy healthy controls (HC) were recruited at ﬁve research sites
in Naples, Foggia, Rome “Tor Vergata”, Rome “Sapienza” and Salerno
as part of the add-on EEG study of the Italian Network for Research on
Psychoses (Mucci et al., 2014).
The SCZ sample included individuals consecutively seen at the
outpatient units of the three mentioned Italian university psychiatric
clinics. All patients had a diagnosis of schizophrenia according to DSM-
IV, conﬁrmed with the Structured Clinical Interview for DSM-IV -
Patient version (SCID-I-P), and an age between 18 and 65 years. The HC
group was matched with SCZ by gender and age, and recruited from the
community at the same sites as the patient sample. Inclusion criteria for
HC were the absence of a current or lifetime Axis I or II diagnosis.
Exclusion criteria for both groups were: (a) a history of head trauma
with loss of consciousness; (b) a history of moderate to severe mental
retardation or of neurological diseases; (c) a history of alcohol and/or
substance abuse in the last six months; (d) current pregnancy or lac-
tation; (e) inability to provide an informed consent. Exclusion criteria
for SCZ were treatment modiﬁcations and/or hospitalization due to
symptom exacerbation in the last three months.
The study has been conducted in accordance with the principles of
the Declaration of Helsinki (59th World Medical Association General
Assembly; October 2008) and with Uniform Requirements for manu-
scripts submitted to Biomedical journals and was approved by the
Ethics Committee of the involved institutions. After a complete de-
scription of the study, a written informed consent was obtained from all
participants.
2.2. Assessments
All subjects were evaluated for socio-demographic variables such as
age, education and gender.
A semi-structured interview, the Brief Negative Symptoms Scale
(Kirkpatrick et al., 2011) was used to assess negative symptoms in in-
dividuals with schizophrenia. The scale comprises 13 items, organized
into six subscales (ﬁve negative symptom subscales: Anhedonia, Aso-
ciality, Avolition, Blunted Aﬀect and Alogia, and a control subscale:
Distress). All the items are rated on a 7-point (0–6) scale, thus ranging
from absent (0) to moderate (3) to extremely severe (6) symptoms
(except distress for which the severity rating is reversed: 0 normal
distress and 6 absent). A total score was calculated by summing the 13
individual items (possible score ranging from 0 to 78); subscale scores
were calculated by summing the individual items within each subscale.
With regard the two domains, Avolition-apathy was computed by
summing the scores on the subscales Anhedonia (consummatory and
anticipatory anhedonia), Avolition, Asociality, with higher scores in-
dicating greater Avolition-apathy (Kirkpatrick et al., 2011). Expressive
deﬁcit was computed by summing the scores on the subscales Blunted
Aﬀect and Alogia (Kirkpatrick et al., 2011).
Patients were also administered the Positive and Negative
Syndrome Scale (Kay et al., 1987). According to the ﬁve-factor model
proposed by Wallwork et al. (2012), we computed the positive di-
mension by summing the scores on the items “Delusions” (P1), “Hal-
lucinatory behavior” (P3), “Grandiosity” (P5) and “Unusual thought
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content” (G9); the disorganization dimension was made up of three
PANSS items: “Conceptual disorganization” (P2), “Diﬃculty in abstract
thinking” (N5), and “Poor attention” (G11) and, ﬁnally, the negative
dimension was assessed by summing the scores on the items “Blunted
Aﬀect” (N1), “Emotional Withdrawal” (N2), “Poor Rapport” (N3),
“Passive/Apathetic Social Withdrawal” (N4) and “Lack of Spontaneity”
(N6). All items are rated on a 7-point scale from 1 to 7, ranging from
absent (1) to moderate (4) to extremely severe (7).
We also assessed depressive symptoms using the Calgary Depression
Scale for Schizophrenia (CDSS) (Addington et al., 2014) and extra-
pyramidal symptoms using the St. Hans Rating Scale (SHRS) for Ex-
trapyramidal Syndromes (Gerlach et al., 1993).
2.3. Recording procedure
EEGs were recorded using two highly comparable EEG recording
systems: EASYS2 (Brainscope, Prague) and Galileo MIZAR-sirius
(EBNeuro, Florence). Before starting the study, a harmonization of the
ampliﬁer settings and recording procedure was carried out to ensure
the same settings in all centers.
All EEGs were recorded using a cap electrode system with 29 uni-
polar leads (Fpz, Fz, Cz, Pz, Oz, F3, F4, C3, C4, FC5, FC6, P3, P4, O1,
O2, Fp1, Fp2, F7, F8, T3, T4, T5, T6, AF3, AF4, PO7, PO8, RM, LM),
placed following the 10–20 system (American Electroencephalographic
Society Guidelines in Electroencephalography, 1994). All leads were
referenced to linked earlobes (a resistor of 10 kΩ was interposed be-
tween the earlobe leads). A ground electrode was placed on the fore-
head.
A horizontal electro-oculogram (HEOG) was recorded from the
epicanthus of each eye, and a vertical EOG (VEOG) from the leads
beneath and above the right eye for artifact monitoring. All impedances
of the leads were kept below 5 kΩ.
The EEG data were ﬁltered with a band-pass of 0.15–70 Hz and
recorded with a sampling rate of 512 Hz. A 50 Hz notch ﬁlter was used.
A calibration was performed for all channels, using a 50 μV sine wave,
before each recording session.
For each recording, subjects were seated in a reclining chair, in a
sound attenuated room and were asked to relax and sit comfortably
while upright with eyes closed, minimizing eye movement or muscle
tension. EEG was continuously recorded for 5min while the subjects
were at rest with closed eyes.
Participants were instructed not to drink coﬀee, tea and abstain
from smoking cigarettes in the 2 hours before the beginning of the re-
cording session and not to take the psychotropic drugs during the
morning. Information on the quality of sleep during the night prior to
the recording was collected and the EEG session was postponed if the
subject reported a non-restoring sleep.
2.4. Data pre-processing
Oﬀ-line analysis was performed by a single expert (G. M. G.) from
the coordinating center (Naples) using Brain Vision Analyzer software
(Brain Products, Munich, Germany). Data with high line noise were
excluded from further analysis. Eye movements and eye blinks were
corrected using independent component analysis (Delorme et al.,
2007). We did not use the interpolation for bad or artefactual channels.
Body movements, muscle activity and technical artifacts were discarded
through visual inspection during centralized artefacting. The data were
parsed into epochs of 2-s duration, digitally ﬁltered from 2 to 20 Hz and
recomputed to the average reference.
2.5. Microstates analysis
The microstate analysis was performed using an in-house plugin for
the Brain Vision Analyzer.
We decided to extract the individual MS parameters using an ex-
isting set of grand mean MS map templates (Fig. 1), which was ex-
tracted from a very large sample of subjects (Koenig et al., 2002). This
methodological approach is justiﬁed by the fact that a recent review of
the literature on MS analysis has revealed general consistencies among
studies for MS classes A, B and D, but some discrepancy in class C
(Michel and Koenig, 2017). The main discrepancy was in the occipital
or parietal focus of the posterior pole. One study (Custo et al., 2017),
which did not impose the 4-MS limit of previous studies, reported two
separate MSs, one with the occipital pole (MS-C) and the other with the
parietal pole (MS-F). The study also reported a very high spatial cor-
relation between the two MSs (r= 0.70). Thus, acknowledging that in
studies imposing the 4 MS limit, the two spatially-correlated MSs (C and
F in their study) are combined in a single MS-C (which might retain
either the parietal or the occipital focus of the posterior pole). Fur-
thermore, Custo's et al. (2017) MS-F showed an association with the
same neural network reported for MS-C by Britz et al. (2010) and MS-C
of Custo et al. (2017) showed an association with a network belonging
to the intrinsic system, i.e., the same functional system of the network
associated with MS-C in the studies conducted by Britz et al., 2010 and
Milz et al., 2016. In studies on schizophrenia, the two topographic
variants were equally represented in diﬀerent studies, independently of
the number of channels used, variance explained or sample size of the
individual studies (Michel and Koenig, 2017). However, all these stu-
dies had limited sample sizes and used quite heterogeneous MS ana-
lyses.
Therefore, in the light of this heterogeneity, we decided to use the
MS map templates from the normative study (Koenig et al., 2002),
which for MS-C might represent a more reliable combination of the two
topographies, as it was extracted in the largest sample of subjects
(N= 496).
Individual EEG data were spatially down-sampled to 19 channels
and all maps at momentary GFP peaks were assigned to the microstate
template maps using a best-ﬁt criterion. Finally, the assignment of the
time-points between GFP peaks was obtained using a nearest neighbor
interpolation.
MSs were then quantiﬁed for each class in terms of their relative
time contribution (percentage of time covered by a given MS class),
duration (average continuous time period in ms covered by a given MS
class), and occurrence (number of distinct microstates of a given MS
class occurring within a 1 s window).
Fig. 1. Microstate normative maps.
MS-A, microstate A; MS-B, microstate B; MS-C, microstate C; MS-D, microstate D.
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To check for eventual inﬂuence of used template maps on main
results, we also performed control analyses, in which the data-driven
approach was adopted to identify the 4 MS template maps, using either
the whole sample or the SCZ data. The methodology and results of the
control analyses are reported in the Supplemental Materials (paragraph
1, Fig. S2 and S3, Tables S5-S7; paragraph 2, Table S8).
2.6. Statistical analyses
Statistics were computed using SPSS Version 22.0 (IBM
Corporation, 2014). Analysis of variance (ANOVA) was used to test
group diﬀerences on continuous variables. Group diﬀerences in sex
distribution were assessed by the Pearson's χ2 test.
With regard to MS parameters, we focused only on contribution and
duration as the occurrence is calculated as the ratio between the latter
two parameters. Therefore, to test group diﬀerences between SCZ and
HC on MS parameters, we performed a repeated measure multivariate
analysis of variance (MANOVA), with MS parameters (contribution and
duration) and MS classes (MS-A, MS-B, MS-C, MS-D) as within-subject
factors and diagnosis (SCZ and HC) as between subjects factor. The
Huynh-Feldt correction for multiple comparisons was applied. Follow-
up univariate ANOVAs for investigation of simple eﬀects were carried
out only when signiﬁcant group main eﬀects or interactions were found
in the MANOVA.
Associations of negative symptoms with MS parameters were as-
sessed using Pearson's correlation coeﬃcients. Only when a signiﬁcant
correlation of BNSS total score with MS measures (contribution and
duration) was observed, correlations of the same parameters with the
two negative symptom domains (Avolition-apathy and Expressive def-
icit) and their component symptoms were further assessed.
Since positive symptoms, depression and extrapyramidal symptoms
might inﬂuence the relationship between MS measures and negative
symptoms, correlations between these variables were also examined
using partial correlation analyses, controlling for PANSS positive score,
CDSS total scores and Parkinsonism global score derived from SHRS.
3. Results
3.1. Subject characteristics
One hundred and forty-eight SCZ and seventy HC were originally
enrolled in the study. However, six patients and six healthy controls
were removed from the ﬁnal study sample as outliers for MS measures
as identiﬁed by using the SPSS outlier detection program: they showed
MS parameter values with deviation (positive) from the third quartile or
(negative) from the ﬁrst quartile> 3 times the interquartile range.
Therefore, one hundred and forty-two SCZ and sixty-four HC were
included in the group-level analysis.
Table 1 summarizes demographic, psychometric and clinical char-
acteristics of HC and SCZ. There was no signiﬁcant group diﬀerence in
sex (χ2= 3.20; p= .07) and age (F=0.36; p= .55), but patients had
signiﬁcantly lower education level than controls (F= 7.97; p= .005).
SCZ were characterized by absent to mild severity of both positive and
disorganization dimensions (PANSS mean dimension score < 9 for
both) and mild to moderate severity of the negative symptoms (PANSS
negative dimension mean score of 15.69 and BNSS total score of 33.05).
They had a low mean level of depression (CDSS total score < 4) and of
parkinsonism (SHRS Parkinsonism score < 1).
Additional clinical information concerning SCZ sample are reported
in the Supplementary Materials (Table S1).
3.2. Group comparison on EEG parameters
3.2.1. Data quality
There was no diﬀerence in the number of 2-second epochs included
in the analysis after exclusion of those with artifacts (F= 0.009;
p= .93) between HC and SCZ (means± SD, 132.75 ± 29.46 and
133.18 ± 30.66, respectively). In addition, there was no recording site
eﬀect on the number of included 2-second epochs for both HC
(F=0.147; p= .864) and SCZ (F=1.133; p= .325).
3.2.2. Group diﬀerences on microstate parameters
The four MS classes explained 66% of the variance in the whole
sample.
Repeated measure MANOVA showed an interaction group x MS
parameters x MS class (F[1204]= 3.44, p < .03), due to diﬀerences in
the contribution (F[1204]= 6.91; p < .009; eﬀect size= 0.4) and
duration (F[1204]= 5.88; p < .016; eﬀect size= 0.37) of MS-C be-
tween HC and SCZ (Fig. 2). Complete results of the MANOVA are re-
ported in the supplementary materials (Table S2). Group means and
standard deviations for all considered parameters and MS classes are
reported in Table S3, together with post-hoc univariate test results.
In addition, as there are more males in the patient group, we carried
out a control analysis, using sex as covariate and we included the results
in the supplementary materials (Table S4).
3.3. Relationship between microstate measures and negative symptoms
BNSS total score was signiﬁcantly correlated with contribution of
MS A (Table 2).
The two negative symptom domains showed a diﬀerent pattern:
while the Avolition-apathy domain correlated positively with the con-
tribution of MS-A, no correlation was found for the Expressive deﬁcit
domain (Table 2; Fig. S1).
Since there was a signiﬁcant correlation between the Avolition-
apathy domain and the MS-A, we computed separate correlations be-
tween component symptoms of Avolition-apathy (consummatory and
anticipatory anhedonia, avolition and asociality) and the contribution
of MS-A. We found that within the Avolition-apathy domain, antici-
patory anhedonia, avolition and asociality, but not consummatory
Table 1
Demographic and clinical characteristics of the study sample.
HC (N=64) SCZ (N=142) F/χ2 p
Demographic and clinical information
Gender (M/F) 34/30 94/48 3.20 0.07
Age (years, mean ± SD) 35.73 ± 12.95 36.71 ± 9.6 0.36 0.55
Education (years,
mean ± SD)
13.67 ± 3.79 12.27 ± 3.03 7.97 0.005
BNSS total (mean ± SD) 33.05 ± 14.1
Expressive deﬁcit
(mean ± SD)
11.84 ± 7.51
Blunted Aﬀect (mean ± SD) 7.68 ± 4.92
Alogia (mean ± SD) 4.16 ± 3.20
Avolition-apathy
(mean ± SD)
18.75 ± 8.56
Anticipatory Anhedonia
(mean ± SD)
3.03 ± 1.52
Consummatory Anhedonia
(mean ± SD)
2.96 ± 1.51
Avolition(mean ± SD) 6.16 ± 2.90
Asociality (mean ± SD) 6.6 ± 2.63
PANSS Positive
(mean ± SD)
8.38 ± 4.56
PANSS Negative
(mean ± SD)
15.69 ± 6.22
PANSS Disorganization
(mean ± SD)
8.56 ± 3.52
CDSS total (mean ± SD) 3.9 ± 4.36
SHRS Global Parkinsonism
(mean ± SD)
0.91 ± 1.17
HC, healthy controls; SCZ, individuals with schizophrenia; BNSS, Brief Negative
Symptom Scale; PANSS, Positive and Negative Syndrome Scale; CDSS, Calgary
Depression Scale for Schizophrenia; SHRS, St. Hans Rating Scale.
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anhedonia, were positively correlated with contribution of MS-A
(Table 2). These correlations remained signiﬁcant after controlling for
the eﬀects of PANSS positive, CDSS total score and SHRS Parkinsonism
Global score (BNSS total score: r= 0.17, p= .05; Avolition-apathy:
r= 0.2, p= .02; anticipatory anhedonia: r= 0.18, p= .04; avolition:
r= 0.18, p= .035; asociality: r= 0.24, p= .006).
4. Discussion
The present study had two primary aims: 1) to identify diﬀerences
between healthy controls and clinically stable individuals with schizo-
phrenia in brain electrical MS parameters and 2) to investigate the
associations of the MS parameters with the Avolition-apathy domain
and its component symptoms, as assessed by a second-generation rating
scale, providing optimal assessment of consummatory and anticipatory
anhedonia.
The main results of our study included: 1) an increased contribution
and duration of MS-C in individuals with schizophrenia, compared to
healthy controls, 2) a relationship between negative symptoms, as-
sessed by BNSS scale, with contribution of MS A, 3) a positive corre-
lation between Avolition-apathy, but not expressive deﬁcit, with con-
tribution of MS-A, and 4) a positive correlation between anticipatory
anhedonia, avolition and asociality, but not consummatory anhedonia
with the contribution of MS-A.
Our results, in line with earlier studies (Koenig et al., 1999;
Lehmann et al., 2005; Kikuchi et al., 2007; Nishida et al., 2013), de-
monstrated that MS of class C covers more of the total time in in-
dividuals with schizophrenia. In addition, Tomescu et al. (2014) re-
ported that adolescents with 22q11.2 deletion syndrome, with higher
Fig. 2. Group comparison on the microstate C parameters.
This ﬁgure illustrates that the procedure results from ﬁtting 4 template maps to the data. The between group comparison indicates which parameters of the four maps
(2 A, contribution; 2 B, duration) are signiﬁcantly diﬀerent between SCZ and HC. This is particularly relevant for the contribution and duration of MS-C.
*A: SCZ, in comparison to HC, showed increased contribution of MS-C (p < .009).
*B: SCZ, in comparison to HC, showed increased duration of MS-C (p < .016).
HC, healthy controls; SCZ, individuals with schizophrenia.
Error bars represent standard error.
Table 2
Correlations between microstate A contribution and negative symptoms in in-
dividuals with schizophrenia.
Brief Negative Symptom Scale Pearson's r p-value
BNSS total score 0.19 0.03
Avolition-apathy 0.22 0.01
Consummatory Anhedonia 0.13 0.13
Anticipatory Anhedonia 0.20 0.02
Avolition 0.20 0.02
Asociality 0.25 0.003
Expressive Deﬁcit 0.12 0.15
BNSS, Brief Negative Symptom Scale.
The contribution of microstate A was positively correlated with BNSS total
score, Avolition-apathy domain, anticipatory anhedonia, avolition and asoci-
ality.
These correlations remained signiﬁcant after controlling for the eﬀects of
PANSS positive, CDSS total score and SHRS Parkinsonism Global score (BNSS
total score: r= 0.17, p= .05; Avolition-apathy: r= 0.2, p= .02; anticipatory
anhedonia: r= 0.18, p= .04; avolition: r= 0.18, p= .035; asociality:
r= 0.24, p= .006).
Bold p-values are those statistically signiﬁcant.
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risk to develop schizophrenia, showed an increased contribution, oc-
currence and duration of MS-C, as compared to healthy controls. The
increased duration of MS-C was associated to prodromal psychotic
symptoms and was proposed as a potential vulnerability marker to
develop schizophrenia. This hypothesis was conﬁrmed by a subsequent
study in which the authors found the same abnormalities of MS-C in
adolescents with 22q11.2 deletion syndrome and in individuals with
schizophrenia (Tomescu et al., 2015).
Furthermore, Koenig et al. (2002), in their across-age study, de-
monstrated that MS-C was more present during late adolescence, the
typical age of onset of schizophrenia symptoms, while decreasing
during adulthood, suggesting that its increase in schizophrenia might
be related to neurodevelopmental aberrations. MS-C increase has been
reported when connections to contextual information are loosened:
during reduced attention states (Brandeis and Lehmann, 1989), psy-
chosis (Rieger et al., 2016), sleep (Brodbeck et al., 2012), reduced
bodily perception states (Pipinis et al., 2017) and hypnosis (Katayama
et al., 2007), conditions that might be associated with an altered ex-
perience of salience. Furthermore, a recent study using simultaneous
EEG and fMRI recording has suggested that MS-C reﬂects the cerebral
activity in the posterior part of the anterior cingulate cortex, bilateral
inferior frontal gyri, the right anterior insula and the left claustrum
(Britz et al., 2010), regions that have been found to be part of the
salience network (Fox et al., 2006; Mantini et al., 2007; Seeley et al.,
2007). Salience has been linked to the capacity in selecting internal or
external stimuli deserving our attention, and aberrant salience attri-
bution has been reported in individuals with schizophrenia (Menon and
Uddin, 2010; Palaniyappan and Liddle, 2012).
In our study we did not ﬁnd any consistent eﬀect in MS of class A, B
and D.
Contrary to the literature, we did not ﬁnd a reduced duration of MS-
D in SCZ as compared to HC (Rieger et al., 2016). The reduced duration
of MS-D has been previously found to correlate with paranoid-halluci-
natory symptomatology (Koenig et al., 1999), and with the acute ex-
perience of hallucinations (Kindler et al., 2011), in drug-free in-
dividuals with schizophrenia. Diﬀerences between our results and
previous studies with regard to MS-D characteristics in individuals with
schizophrenia might be explained by the inclusion in our study of a
sample of chronic, clinically stable, medicated individuals with schi-
zophrenia, in which more than half of the subjects had remitted hal-
lucinatory-paranoid and disorganized symptomatology. Our results
suggest that the heterogeneity of the clinical characteristics of included
samples might explain discrepant ﬁndings in the literature. Discrepant
ﬁndings in our study concerning the MS-D could also result from the
diﬀerent methodological approaches, as previous studies that reported
increased MS-C and decreased MS-D used data-driven template maps,
rather than the normative templates. However, the conﬁrmation of the
increased duration and contribution of MS-C argues against a role of the
MS analysis method in explaining the inconsistencies. Furthermore, in
our control analysis in which we compared the two groups using the
data-driven approach, we could not replicate the ﬁndings concerning
MS-D. These considerations argue against the hypothesis that metho-
dological diﬀerences might account for the discrepancies concerning
MS-D. However, only investigations including both subjects with acute
psychotic decompensation and those clinically-stable, as well as the two
methods of MS analysis might further clarify the issue.
For the overall view on microstate studies, it is also important to
note that the topography of microstate classes C and D has shown a
substantial amount of variation across studies, that may at one point
have to be systematically scrutinized across the range of existing mi-
crostate investigations in schizophrenia.
Our results concerning MS-B and MS-A were expected. Indeed, the
small eﬀect size for reduced duration of MS-B reported in a recent meta-
analysis, did not survive Bonferroni correction (Rieger et al., 2016),
suggesting heterogeneity across studies. The same meta-analysis did not
ﬁnd a consistent group eﬀect for MS-A (Rieger et al., 2016). For this MS,
discrepant ﬁndings were reported: MS-A was found to occur more fre-
quently (Lehmann et al., 2005; Nishida et al., 2013), to cover more
percent of time (Lehmann et al., 2005) and to have a reduced duration
(Strelets et al., 2003; Nishida et al., 2013) in individuals with schizo-
phrenia as compared to healthy controls. In our study, no diﬀerence on
MS-A parameters between individuals with schizophrenia and healthy
controls was observed, although we found a correlation between MS-A
contribution and Avolition-apathy. Our results might help under-
standing the discrepancies in the literature ﬁndings concerning this
microstate. In fact, negative symptoms, even those which have the
highest frequency, such as Avolition-apathy, are generally present at a
clinically-signiﬁcant level in about one half of the patient population.
When comparing the whole group of patients with healthy controls, the
deviance may not be statistically detectable due to the heterogeneity of
the patient sample with respect to negative symptoms. Therefore, the
discrepancy in the diﬀerent studies concerning this MS might be due to
diﬀerences in the frequency and severity of negative symptoms in in-
cluded samples.
Our study demonstrated a relationship of MS-A contribution with
the negative symptom domain of Avolition-apathy which, as docu-
mented by partial correlation analysis, was not mediated by positive
symptoms, extrapyramidal symptoms or depression, frequently causing
secondary negative symptoms. No correlation was found between the
Expressive deﬁcit domain and MS-A. These results support the view
that, in individuals with schizophrenia, Avolition-apathy and
Expressive deﬁcit have diﬀerent neurobiological underpinnings
(Galderisi et al., 2013a; Kirkpatrick, 2014b; Mucci et al., 2015; Kaiser
et al., 2016; Kirkpatrick et al., 2017; Mucci et al., 2017). The ﬁndings
were not biased by the type of microstate analysis used in our study, as
they were replicated in control analyses using two further methods, i.e.,
ﬁtting to the patient data the template maps derived by combining data
of our healthy control and patient groups or using data from the patient
group alone.
With regard to component symptoms, within Avolition-apathy, we
found that only avolition, asociality and anticipatory anhedonia, but
not consummatory anhedonia correlated with MS-A. These ﬁndings
lend support to the hypothesis that only anticipatory anhedonia might
be linked to the Avolition-apathy domain of negative symptoms.
Anticipatory pleasure is important to formulate, maintain and complete
goals (Barch and Dowd, 2010; Simpson et al., 2012). Research has
shown the so called “emotion paradox” in individuals with schizo-
phrenia (Pizzagalli, 2010; Strauss, 2013). In fact, they have apparently
intact aﬀective responses to stimuli that produce hedonistic experiences
in the present but they are impaired in generating representations of
hedonic values for past (e.g., report of experienced consummatory
pleasure) or future experiences (anticipatory pleasure) and in in-
tegrating information on value with the selection of an action (Gard
et al., 2007; Heerey and Gold, 2007; Heerey et al., 2007; Waltz et al.,
2007; Kring and Moran, 2008; Barch and Dowd, 2010; Cohen and
Minor, 2010; Foussias and Remington, 2010; Pizzagalli, 2010; Dowd
and Barch, 2012; Simpson et al., 2012; Mann et al., 2013; Strauss, 2013;
Morris et al., 2015; Mucci et al., 2015). In our sample, individuals with
schizophrenia had comparable levels of anticipatory and con-
summatory anhedonia in terms of means and standard deviations, and
percentages of moderate to severe scores (67% for anticipatory and
61% for consummatory anhedonia). However, only anticipatory anhe-
donia was found to correlate with the same electrophysiological marker
as avolition-apathy. The lack of correlation of consummatory anhe-
donia with MS-A contribution does not seem to be due to reduced
frequency or severity of this symptom in our sample. Future replications
of these results might shed further light on the apparent “emotion
paradox” in schizophrenia. In fact, the clinical assessment of both
consummatory and anticipatory anhedonia is dependent on the ability
of patients to generate hedonic representations (for the past and future
experiences, respectively) which might be inﬂuenced by cognitive
dysfunctions of the subjects (Strauss, 2013). The diﬀerent pattern of
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correlation with MS-A temporal parameters strongly suggests a sub-
stantial proportion of non-shared variance between the two types of
anhedonia.
The occurrence of both consummatory and anticipatory anhedonia
might be due to the presence of depression. However, our sample did
not show clinically-signiﬁcant levels of depression (as documented by
the low CDSS mean score) which might confound the correlational re-
sults and the assessment of negative symptoms. Furthermore, partial-
ling out the eﬀect of depression, the correlation between increased MS-
A contribution and anticipatory anhedonia remained signiﬁcant.
Previous ﬁndings on MS temporal parameters in individuals with de-
pression reported decreased overall MS duration (Strik et al., 1995), but
the authors did not investigate the symptom correlates of the ab-
normality. In future analyses it could be of interest to carry out a study
on the electrophysiological correlates of anhedonia in subjects with
depression.
The clinical implications of the relationship between MS-A and
Avolition-apathy are still speculative, as the functional role of this MS is
not fully understood. However, two studies (Britz et al., 2010; Milz
et al., 2016) contributed to characterize this MS as the one related to
the RSN devoted to extrinsic processing, i.e., to the M2 system ac-
cording to Doucet et al. (2011). This network is involved in processing
of signals from the external world (Doucet et al., 2011; Orliac et al.,
2017). In fact, the study by Britz et al. (2010) reported that MS of class
A correlated with cerebral activity in the bilateral superior and middle
temporal gyri, regions of the phonological network, as well as in pri-
mary visual areas (Damoiseaux et al., 2006; Mantini et al., 2007), which
are core regions of M2 (Doucet et al., 2011). The more recent study by
Milz et al. (2016) reported an increase of MS-A parameters during vi-
sualization, establishing a possible link to core connectivity patterns
included in the M2b. For the other MS classes, Britz et al. (2010) found
associations with networks belonging to the M1 or intrinsic processing
module (as reported above, MS-C was associated with core regions of
the salience circuit and MS-D with those of the attentional network).
The association of Avolition-apathy with MS-A might indicate a
relationship of this domain of negative symptoms with sensory pro-
cessing abnormalities. These abnormalities have been described in in-
dividuals with schizophrenia and are related to functional outcome
(Green et al., 1994; Rassovsky et al., 2004; Green et al., 2012). Im-
portantly, this relationship was mediated by social perception
(Rassovsky et al., 2004) and by negative symptoms (Rassovsky et al.,
2011; Green et al., 2012). Within negative symptoms, anhedonia, aso-
ciality and avolition, rather than blunted aﬀect and alogia, signiﬁcantly
predicted the functional outcome and explained the relationship be-
tween early visual processing and functioning (Rassovsky et al., 2011).
In the light of these observations, our results seem to conﬁrm the re-
lationship between sensory processing deﬁcits and the Avolition-apathy
domain.
The main strengths of the present study included the use of the
resting state MS and the assessment of negative symptom domains using
the BNSS scale.
Certain limitations of this study should be taken into account.
Contrary to other studies, our analyses were based on previously pub-
lished normative MS templates rather than on templates obtained from
the dataset itself, to overcome the problem of the topographic hetero-
geneity of the MS-C template across studies in individuals with SCZ.
The use of diﬀerent templates might inﬂuence the results and all the
studies were limited by small sample sizes. We explained in the
methods section why we decided to use the template maps. However,
the new method is not uncontroversial and points to a larger problem in
the EEG MS literature in general. Since the MS-C template maps vary
considerably across studies, implying that the overlap of their func-
tional correlates may only be partial, future studies on EEG MS should
provide the employed template maps, so that other studies can test and
compare the functional conclusions that they yield. However, we can
exclude an inﬂuence of the template maps used on our results as they
were conﬁrmed in a control analysis on both MS parameters diﬀerences
between groups and in their clinical correlates.
In addition, age and pharmacological treatment might have an im-
pact on MS measures. In our study, we used a sample in which subjects
were matched for age: therefore, we could exclude the eﬀect of age on
the diﬀerences between healthy controls and individuals with schizo-
phrenia.
With regard to medication, the typical pattern of MS abnormalities
in individuals with schizophrenia has been reported both before and
after treatment with antipsychotics (Kikuchi et al., 2007). Therefore,
our results concerning the diﬀerences between individuals with schi-
zophrenia and healthy controls on MS-C do not seem to be related to
pharmacological treatment. Moreover, we excluded the confounding
eﬀect of medication on correlation between MS-A contribution and
Avolition-apathy, using partial correlation analysis in which we con-
trolled for extrapyramidal symptoms that might cause secondary ne-
gative symptoms.
5. Conclusions
In conclusion, in line with previous studies, our results suggested
that chronic individuals with schizophrenia have an increased con-
tribution and duration of MS of class C.
In addition, for the ﬁrst time, we report a correlation of MS-A
contribution with the Avolition-apathy but not with the Expressive
deﬁcit domain of negative symptoms. These results are in line with
those reporting the existence of diﬀerent neurophysiological correlates
of the two negative symptom domains. Within the Avolition-apathy
domain only the anticipatory component of anhedonia, shares the same
neurophysiological correlates of this domain.
Given the association of MS-A with the extrinsic resting state net-
works, the correlation between this MS and the Avolition-apathy do-
main suggests that motivational deﬁcits in schizophrenia might be
subtended by sensory processing abnormalities, in line with other lit-
erature ﬁndings (Green et al., 2012). Further studies, using simulta-
neous EEG and functional magnetic resonance imaging, might conﬁrm
the relationship between MS-A and extrinsic resting state networks.
If our ﬁndings will be replicated, the detection of MS-A abnormal-
ities could help in stratifying patients to reduce clinical heterogeneity
for treatment development.
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